Cohera Medical said today that it agreed to let B. Braun Medical exclusively market its TissuGlu surgical adhesive in Germany, Spain and Portugal.
B. Braun to market Cohera’s TissuGlu in Europe
Tissue sealer
FDA panel narrowly OKs Cohera Medical’s TissuGlu
Updated August 4, 2014 at 11:30 a.m. with comments from panel members.
The FDA’s General & Plastic Surgery Devices Advisory Panel today narrowly recommended approval for Cohera Medical‘s polyurethane-based TissuGlu adhesive for the approximation of tissue layers to bind subcutaneous dead space between the tissue planes in large flap surgical procedures, including abdominoplasty.
Cohera Medical wins FDA panel date for TissuGlu surgical adhesive
Cohera Medical said it’s won a date with an FDA advisory panel in August for its TissuGlu surgical adhesive.
Tenaxis Medical hauls in $1M
Tenaxis Medical said it brought in close to $1.4 million in a still-open funding round.
The Mountain View, Calif.-based medical device company develops and commercializes surgical sealants for vascular and general procedures.
GPO: Premier awards Technology Breakthroughs contract to Olympus America
Olympus America, a Center Valley, Pa.-based commercial camera and medical supply maker, landed a contract to supply surgical tools to members of group purchasing organization Premier healthcare alliance.
Ethicon lands FDA nod for cordless Enseal G2 tissue sealer
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon won 510(k) clearance from the FDA for its next-generation Enseal tissue sealing device with a self-contained power source.
